Stocks / NASDAQ / Compugen Ltd.

Compugen Ltd.

Our Opinion

Compugen Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for clinical research and therapies.

Supporting Evidence:

Compugen Announces Positive Animal Model Results for Novel Peptide Predicted to Block Protein-Protein Interaction

In the following press release company said, “The animal model which was then used for in vivo validation was lipopolysaccharide (LPS)-induced endotoxemia, a model for septic shock, which leads to animal death. In these experiments, CGEN-25068 was shown to significantly increase the survival rate of the animals.”

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. [Source: MarketWatch]

Company Website: